Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.10.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets and Liabilities

As of December 31, 2018 and 2017, the Company’s deferred tax assets (liabilities) consisted of the effects of temporary differences attributable to the following:

 

 

 

December 31,

 

 

 

2018

 

 

2017

 

Deferred tax assets (liabilities):

 

 

 

 

 

 

 

 

Tax credit

 

$

5,994,401

 

 

$

4,335,394

 

Net operating loss carryforwards

 

 

36,578,319

 

 

 

23,630,008

 

Property and equipment

 

 

144,833

 

 

 

99,756

 

Research and development costs

 

 

16,303,445

 

 

 

15,372,328

 

Start-up and organizational costs

 

 

696

 

 

 

774

 

Stock-based compensation

 

 

4,000,781

 

 

 

2,473,591

 

Other accruals

 

 

326,812

 

 

 

260,113

 

Total gross deferred tax assets

 

 

63,349,287

 

 

 

46,171,964

 

Less: valuation allowance

 

 

(63,349,287

)

 

 

(46,171,964

)

Deferred tax assets, net

 

$

 

 

$

 

Summary of Valuation Allowance

The change in the Company’s valuation allowance is as follows:

 

 

 

2018

 

 

2017

 

January 1,

 

$

46,171,964

 

 

$

39,719,606

 

Increase in valuation allowance

 

 

17,177,323

 

 

 

6,452,358

 

December 31,

 

$

63,349,287

 

 

$

46,171,964

 

Schedule of Effective Income Tax Rate Reconciliation

 

 

 

For the Year Ended December 31,

 

 

 

2018

 

 

2017

 

Tax benefit at federal statutory rate

 

 

(21.0

)%

 

 

(34.0

)%

State income taxes

 

 

(7.7

)

 

 

(10.2

)

Permanent differences:

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

(2.2

)

 

 

(2.5

)

Meals and entertainment

 

 

0.1

 

 

 

0.1

 

Executive compensation

 

 

0.2

 

 

 

 

True-up of federal deferred taxes

 

 

0.1

 

 

 

(2.8

)

Change in effective tax rate

 

 

 

 

 

39

 

Research and development tax credit, federal

 

 

(1.9

)

 

 

(1.4

)

Research and development tax credit, state

 

 

(1.4

)

 

 

(1.6

)

Increase in valuation allowance, federal

 

 

24.7

 

 

 

1.3

 

Increase in valuation allowance, state

 

 

9.1

 

 

 

11.7

 

Effective income tax rate

 

 

0.0

%

 

 

0.0

%